Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer.
about
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative ActivitySantacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca spStudies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells.Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases.Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signalingHistone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphomaTowards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.Analysis of class I and II histone deacetylase gene expression in human leukemia.Exploring the epigenetic drug discovery landscape.Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.
P2860
Q27853165-D0BC7CDD-FC7C-4E3E-BBC4-3A606A3EE6FDQ28551721-9796B54F-6746-49B9-ACD1-DF23E09EC683Q30684975-99A34D18-33A6-494A-9033-06CC2E02A9D3Q33570972-3F403E07-5F63-41D8-9F85-7C718B15D507Q35194759-41460BBF-6E86-4892-8CCF-69143FE9FB10Q36242646-C2CAF7CB-369C-4136-B46B-458C8DA962EBQ36301520-315FDCD6-E545-40A8-9396-987D160F251FQ37144116-EBC65161-E2C3-436A-AC70-370CEDBB2DF3Q37439209-83548A20-F15E-40A7-B5E4-66585D24C4B2Q38204386-B2D0CD21-EB92-44B5-97BA-EC9EE28A2991Q38588663-4AEA8B7A-47E4-4F3B-8C4A-560266DCE44DQ38748410-510B7137-8023-4911-817E-08947A41BE52Q38822524-BE6B1AF7-5A81-48C6-8DFB-B4B8379C6A74
P2860
Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Toward isozyme-selective inhib ...... s for the treatment of cancer.
@en
type
label
Toward isozyme-selective inhib ...... s for the treatment of cancer.
@en
prefLabel
Toward isozyme-selective inhib ...... s for the treatment of cancer.
@en
P2093
P2860
P356
P1476
Toward isozyme-selective inhib ...... s for the treatment of cancer.
@en
P2093
Amy C Anderson
Dennis L Wright
Eric M Falcone
Michael van Heyst
Sophia N Ononye
P2860
P304
P356
10.4155/PPA.12.21
P577
2012-05-01T00:00:00Z